CALCIUM OXYBATE is a small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020. The directory classifies it as a unknown/inactive API with a synthetic source/manufacturing origin. Other names for this substance include Oxybate Calcium and Calcium bis(4-hydroxybutanoate). It is listed as a controlled drug substance (Schedule III). Its PubChem CID is 6100372.
Calcium oxybate
| CAS No | 82316-97-0 |
|---|---|
| Molecular Formula | C8H14CaO6 |
| Molecular Weight | 246.27 g/mol |
| Synonyms | calcium;4-hydroxybutanoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
CALCIUM OXYBATE is a small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020. The directory classifies it as a unknown/inactive API with a synthetic source/manufacturing origin.
The listed CAS number is 82316-97-0.
The listed molecular formula is C8H14CaO6.
The listed molecular weight is 246.27 g/mol.
calcium;4-hydroxybutanoate.
The source lists Oxybate Calcium and Calcium bis(4-hydroxybutanoate).